Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Participants
NCT04484857
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
283
Enrollment
INDUSTRY
Sponsor class
Conditions
Anemia Associated With End Stage Renal Disease
Interventions
DRUG:
Roxadustat
Sponsor
Kyntra Bio
Collaborators
[object Object]